(Q35045253)

English

One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

Helicobacter pylori

object named as

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Maria Aparecida Mesquita

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sonia Letícia Silva Lorena

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jazon Romilson Souza Almeida

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ciro Garcia Montes

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Fábio Guerrazzi

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Luciana T Campos

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

José Murilo Rubiota Zeitune

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3566-3569

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Review article: Helicobacter pylori and reflux disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Regular review: treatment of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

New options in Helicobacter pylori eradication: efficacy, resistance and synergy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

8 July 2018

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V11.I23.3566

21 January 2018

A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4315962

25 October 2018

High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of Helicobacter pylori eradication on peptic ulcer healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15962376

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V11.I23.3566

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35045253&oldid=2087507947"